Results 81 to 90 of about 5,178 (152)

Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC. [PDF]

open access: yesMol Med, 2023
Zhao J   +18 more
europepmc   +1 more source

Corrigendum to "Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations" [Saudi Pharm. J. 31(6) (2023) 1061-1067]. [PDF]

open access: yesSaudi Pharm J, 2023
Tiwari A   +12 more
europepmc   +1 more source

Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α. [PDF]

open access: yesDrug Des Devel Ther, 2022
Zhao J   +13 more
europepmc   +1 more source

Effect of Plant Density on Growth and Bioactive Compounds in Salvia miltiorrhiza

open access: yesAgronomy
Danshen (Salvia miltiorrhiza) is an herbaceous plant widely used in the pharmaceutical industry. However, the majority of medicinal plants utilized in the US are imported, posing challenges such as fluctuations in bioactive compound concentrations and ...
Zhiheng Xing   +4 more
doaj   +1 more source

Tanshinone I Mitigates Steroid-Induced Osteonecrosis of the Femoral Head and Activates the Nrf2 Signaling Pathway in Rats. [PDF]

open access: yesEvid Based Complement Alternat Med, 2021
Xu X   +7 more
europepmc   +1 more source

Protective effects of tanshinone Ⅰ against cisplatin-induced nephrotoxicity in mice. [PDF]

open access: yesIran J Basic Med Sci, 2022
Wang Y   +10 more
europepmc   +1 more source

MAPK3-MYB36-ARF1 module regulates the tanshinone formation in Salvia miltiorrhiza

open access: yesPlant Signaling & Behavior
Salvia miltiorrhiza, known as Danshen, is a traditional Chinese medicinal plant with significant cardiovascular benefits, attributed to its secondary metabolites, particularly tanshinones. Despite their medicinal value, tanshinones occur in low natural abundance, necessitating research to increase their content.
Yongfeng Xie, Hao Liu
openaire   +3 more sources

Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2. [PDF]

open access: yesTheranostics, 2021
Huang Y   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy